Nikko Asset Management Americas’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,490,600	Closed	-$17.5M	–	197
2023 Q2	$17.5M	Sell	2,490,600 -58,391	-2%	-$418K	0.18%	74
2023 Q1	$15.4M	Sell	2,548,991 -38,627	-1%	-$267K	0.18%	66
2022 Q4	$16.5M	Sell	2,587,618 -111,795	-4%	-$873K	0.24%	64
2022 Q3	$25.2M	Sell	2,699,413 -100,229	-4%	-$1.16M	0.32%	56
2022 Q2	$29.7M	Buy	2,799,642 +421,306	+18%	+$5.52M	0.37%	58
2022 Q1	$39.2M	Sell	2,378,336 -2,586,760	-52%	-$40M	0.29%	64
2021 Q4	$82.6M	Sell	4,965,096 -1,415,707	-22%	-$31.2M	0.43%	45
2021 Q3	$145M	Sell	6,380,803 -1,343,985	-17%	-$31.7M	0.62%	40
2021 Q2	$199M	Buy	7,724,788 +2,378,927	+45%	+$61.8M	0.78%	39
2021 Q1	$169M	Buy	5,345,861 +921,951	+21%	+$38.2M	0.83%	40
2020 Q4	$205M	Buy	4,423,910 +904,165	+26%	+$35.9M	1.17%	31
2020 Q3	$116M	Buy	3,519,745 +765,177	+28%	+$23.5M	1.03%	35
2020 Q2	$75.4M	Buy	2,754,568 +1,634,046	+146%	+$53.7M	0.99%	32
2020 Q1	$33.5M	Sell	1,120,522 -205,987	-16%	-$5.46M	0.62%	42
2019 Q4	$36.7M	Sell	1,326,509 -29,793	-2%	-$678K	0.58%	48
2019 Q3	$24.7M	Buy	1,356,302 +92,206	+7%	+$2.04M	0.44%	57
2019 Q2	$31M	Buy	1,264,096 +801,026	+173%	+$12.1M	0.61%	45
2019 Q1	$4.4M	Buy	+463,070	New	+$4.5M	0.12%	116